NSCLC Coverage From Every Angle
Advertisement
Advertisement

Active CE Activities

Integrating Targeted Strategies in NSCLC
Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Non-Small Cell Lung Cancer
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care-Lung Cancer: Advanced Disease
One of These Is Not Like the Other: Pathology Reports in Advanced NSCLC
Advanced NSCLC: What Would You Do?
Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC
Clinical Pearls in the Management of Patients With Advanced Non-Small Cell Lung Cancer
EGFR-Mutated NSCLC and CNS Involvement: The Conundrum
For Pulmonologists by Pulmonologists: Diagnosis of NSCLC in an Age of Biomarkers
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Lung Cancer: Early Stage Disease
The Emerging Role of Molecular Testing in an Era of Precision Medicine - Non–Small Cell Lung Cancer
An Advanced Practitioner’s Guide to Cell Signaling Pathways in NSCLC
Optimizing Outcomes in Advanced NSCLC
Advanced Non-Small Cell Lung Ccancer Patient Management Simulator
NCCN Launches NCCN Congress Webinar Series™: Biomarkers 101
Oncology Grand Rounds Series: Part 1 — Non-Small Cell Lung Cancer: A satellite symposium held at the 2017 ONS Annual Congress
Outcomes in NSCLC: A Focus on Quality Improvement - Part 2
Outcomes in NSCLC: A Focus on Quality Improvement - Part 1
EXPERT EXCHANGE: Management of Advanced EGFR Mutation-Positive NSCLC: Making Bold Strides Toward True Precision Medicine
Integrating Targeted Strategies in NSCLC
Checkpoint Inhibitors in First-Line Advanced NSCLC: What Should You Know?
Treatment of EGFR-Mutated NSCLC: Assessing Your Clinical Practice
Case Studies in ALK-Translocated Advanced NSCLC: From Diagnosis to Treatment
ASTRO Issues New Guidelines on Stereotactic Radiation in Early NSCLC
Immunotherapy in Advanced NSCLC: Will Combination Therapies Become Standard?
Clinical Challenges and Best Practices in Managing ALK-Positive NSCLC
Integration of Immunotherapies Into the Treatment of Patients With Non–Small Cell Lung Cancer
Lung Cancer series
NCCN Continuing Education in Lung Cancer